Friday 6 November 2026
Export HCSG’s income statement to Excel — free account
Healthcare Services Group, Inc.
HCSG Healthcare Medical Care Facilities
Healthcare Services Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, up 7.08% from fiscal 2024.
- Revenue
- +3.29%
- EPS
- −37.3%
- Free cash flow
- −59.8%
Quarter to September 2026, against a year earlier
25.13
1.41
−5.31%
Follow HCSG
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
23.32 | 21.52 | 20.08 | 26.92 | 27.15 | 21.29 | 28.28 | 35.53 | 42.99 | 36.09 |
Piotroski F-Score |
8 | 6 | 7 | 4 | 3 | 7 | 6 | 4 | 3 | 7 |
P/S ratio |
0.75 | 0.50 | 0.47 | 0.55 | 0.81 | 1.19 | 0.98 | 1.48 | 2.03 | 1.80 |
Altman Z-Score |
6.55 | 4.96 | 4.56 | 5.17 | 5.69 | 7.86 | 8.03 | 11.42 | 12.71 | 13.77 |
P/FCF ratio |
9.94 | 34.73 | 20.68 | 0.00 | 42.08 | 9.85 | 20.23 | 39.26 | 1,471.95 | 77.55 |
Altman Z″-Score (non-manufacturers) |
6.81 | 6.00 | 5.55 | 5.52 | 5.73 | 6.92 | 6.78 | 6.95 | 6.87 | 8.08 |
Beneish M-Score |
(3.09) | (2.37) | (2.52) | (1.96) | (2.24) | (3.56) | (2.65) | (2.32) | (1.69) | (1.96) |
P/Operating CF |
79.59 | 23.67 | 15.99 | 40.59 | 42.42 | 27.74 | 135.38 | 538.46 | 839.48 | 802.33 |
P/B ratio |
2.71 | 1.71 | 1.73 | 2.22 | 2.94 | 4.37 | 3.93 | 6.75 | 9.46 | 8.29 |
Price to Tangible BV |
3.27 | 2.07 | 2.14 | 2.84 | 3.73 | 5.10 | 4.67 | 8.19 | 11.90 | 10.04 |
EV/Sales |
0.66 | 0.44 | 0.40 | 0.49 | 0.70 | 1.05 | 0.92 | 1.45 | 2.01 | 1.74 |
EV/EBITDA |
18.37 | 12.21 | 10.36 | 11.81 | 15.49 | 13.80 | 18.23 | 26.74 | 27.87 | 21.41 |
EV/Operating CF |
8.31 | 24.23 | 15.36 | (101.96) | 31.05 | 8.47 | 18.17 | 36.25 | 489.78 | 65.66 |
EV/FCF |
8.65 | 30.24 | 17.48 | (64.13) | 36.43 | 8.63 | 19.02 | 38.31 | 1,453.52 | 75.02 |
Quick Ratio |
3.16 | 2.69 | 2.45 | 2.46 | 2.55 | 3.21 | 3.09 | 2.72 | 2.51 | 3.60 |
Current Ratio |
3.38 | 2.89 | 2.64 | 2.69 | 2.86 | 3.53 | 3.47 | 3.11 | 2.86 | 4.11 |
Net Debt/EBITDA |
(3.11) | (2.22) | (1.90) | (1.37) | (2.40) | (1.94) | (1.16) | (0.67) | (0.35) | (0.72) |
Debt/Assets |
0.00% | 0.00% | 3.16% | 3.47% | 0.84% | 0.68% | 1.38% | 4.33% | 5.23% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.05 | 0.06 | 0.01 | 0.01 | 0.02 | 0.07 | 0.09 | 0.00 |
Asset Turnover |
2.30 | 2.15 | 2.21 | 2.26 | 2.10 | 2.34 | 2.60 | 2.93 | 3.09 | 3.10 |
Operating CF/Net income |
2.45 | 0.78 | 1.13 | (0.24) | 0.76 | 2.20 | 1.45 | 0.96 | 0.09 | 0.53 |
Capex/Depreciation |
(0.33) | (0.38) | (0.32) | (0.27) | (0.32) | (0.25) | (0.27) | (0.40) | (0.50) | (0.56) |
Interest Coverage |
30.72 | 6.99 | 6.11 | 17.73 | 41.49 | 85.30 | 22.51 | 31.62 | 90.89 | 58.88 |
| 11.69% | 8.25% | 8.77% | 7.86% | 10.40% | 20.98% | 14.33% | 19.87% | 23.88% | 24.37% | |
| 7.40% | 4.95% | 5.08% | 4.57% | 6.21% | 13.09% | 9.13% | 12.21% | 14.65% | 15.34% | |
ROIC |
9.90% | 7.73% | 8.97% | 10.29% | 13.11% | 33.08% | 13.82% | 16.60% | 21.96% | 29.76% |
Return on Tangible Assets |
13.62% | 10.06% | 10.01% | 10.00% | 12.66% | 22.60% | 16.31% | 23.35% | 24.73% | 23.65% |
Average Days of Receivables |
66.51 | 81.34 | 83.75 | 74.16 | 67.18 | 53.05 | 67.60 | 62.30 | 74.27 | 63.36 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
10.39% | 10.67% | 9.98% | 8.30% | 10.54% | 8.57% | 8.15% | 6.82% | 6.81% | 6.75% |
Intangible Assets out of Total Assets |
0.11 | 0.11 | 0.11 | 0.13 | 0.12 | 0.09 | 0.10 | 0.11 | 0.12 | 0.11 |
Share Based Compensation of Revenue |
0.65% | 0.53% | 0.54% | 0.55% | 0.54% | 0.45% | 0.37% | 0.29% | 0.32% | 0.27% |
Graham Net Nets |
0.21 | 0.30 | 0.30 | 0.22 | 0.17 | 0.13 | 0.14 | 0.09 | 0.07 | 0.08 |
Graham Number |
11.40 | 9.08 | 8.56 | 7.67 | 9.45 | 13.82 | 10.94 | 12.31 | 12.13 | 10.59 |
Earnings Yield |
4.29% | 4.65% | 4.98% | 3.71% | 3.68% | 4.70% | 3.54% | 2.81% | 2.33% | 2.77% |
Free Cash Flow Yield |
10.06% | 2.88% | 4.83% | (1.40%) | 2.38% | 10.15% | 4.94% | 2.55% | 0.07% | 1.29% |
Revenue per Share |
25.38 | 23.26 | 22.50 | 22.74 | 21.95 | 23.57 | 24.75 | 27.06 | 25.37 | 21.48 |
Operating CF per Share |
2.00 | 0.42 | 0.59 | (0.11) | 0.50 | 2.91 | 1.26 | 1.08 | 0.10 | 0.57 |
Capex per Share |
(0.08) | (0.08) | (0.07) | (0.06) | (0.07) | (0.05) | (0.06) | (0.06) | (0.07) | (0.07) |
Free Cash Flow per Share |
1.92 | 0.33 | 0.51 | (0.17) | 0.42 | 2.85 | 1.20 | 1.02 | 0.04 | 0.50 |
Cash per Share |
2.82 | 1.84 | 1.99 | 1.63 | 2.48 | 3.54 | 1.59 | 1.38 | 1.13 | 1.26 |
Shareholders Equity per Share |
7.05 | 6.78 | 6.15 | 5.63 | 6.05 | 6.43 | 6.19 | 5.96 | 5.45 | 4.66 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
7.05 | 6.78 | 6.15 | 5.63 | 6.05 | 6.43 | 6.19 | 5.96 | 5.45 | 4.66 |
Free Cash Flow |
139.26 | 24.68 | 38.21 | (12.98) | 31.63 | 213.15 | 89.41 | 75.73 | 2.57 | 36.23 |
Working Capital |
406.04 | 364.11 | 354.77 | 319.62 | 355.26 | 410.14 | 367.08 | 344.75 | 343.24 | 313.75 |
Capital Expenditures |
(5.71) | (6.12) | (5.28) | (4.82) | (5.48) | (4.07) | (4.17) | (4.30) | (5.06) | (5.17) |
Net Current Asset Value |
292.37 | 253.81 | 237.66 | 206.08 | 221.53 | 267.83 | 253.45 | 256.31 | 251.36 | 225.02 |
EV/EBIT |
24.83 | 16.57 | 13.92 | 15.72 | 20.05 | 15.70 | 21.83 | 29.65 | 30.17 | 23.08 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
28.51 | 19.03 | 16.48 | 17.54 | 23.16 | 17.91 | 23.22 | 30.39 | 30.55 | 23.86 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.62 | 0.57 | 0.57 | 0.76 | 0.60 | 0.61 | 0.53 | 0.83 | 0.75 | 0.69 |
Cash ROIC |
19.50% | 3.88% | 6.07% | (2.30%) | 4.91% | 28.42% | 15.20% | 13.21% | 0.50% | 8.42% |
Accounts Receivable Turnover |
5.12 | 4.48 | 4.60 | 5.24 | 5.88 | 5.90 | 5.39 | 5.56 | 5.73 | 6.43 |
Accounts Payable Turnover |
20.16 | 18.10 | 19.23 | 22.56 | 24.20 | 27.98 | 27.84 | 26.02 | 27.44 | 31.75 |
Inventory Turnover |
95.26 | 84.46 | 73.49 | 63.45 | 49.01 | 43.83 | 41.38 | 42.18 | 40.17 | 36.15 |
Average Days of Payables |
17.68 | 19.91 | 20.85 | 16.65 | 16.66 | 12.78 | 12.32 | 12.69 | 16.88 | 11.69 |
Days of Inventory on Hand |
3.84 | 4.11 | 4.63 | 5.16 | 6.73 | 7.73 | 8.26 | 8.56 | 9.61 | 10.30 |
Average Receivables |
358.56 | 382.92 | 363.46 | 322.80 | 279.03 | 298.40 | 341.38 | 360.28 | 325.00 | 243.07 |
Average Payables |
79.26 | 82.19 | 75.76 | 66.36 | 58.33 | 53.33 | 57.94 | 67.97 | 58.69 | 42.19 |
Average Inventory |
16.77 | 17.61 | 19.82 | 23.59 | 28.80 | 34.05 | 38.98 | 41.92 | 40.10 | 37.05 |
Average Assets |
798.51 | 796.71 | 755.74 | 749.18 | 781.28 | 753.81 | 707.60 | 684.30 | 602.22 | 504.70 |
Average Common Equity |
505.07 | 478.27 | 437.45 | 435.48 | 466.57 | 470.38 | 450.54 | 420.37 | 369.40 | 317.65 |
Columns are period end dates · fundamentals updated 2 Nov 2026